drugset / Trial / NCT00081627

Clinical Trial in Patients With Metastatic Colorectal Cancer

NCT00081627 ↗

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The objectives of this trial are to determine if CoFactor in combination with 5-FU are effective in the treatment of metastatic colorectal cancer and to determine the side effects observed with the administration of CoFactor and 5-FU.

Timeline

Start
2004-04
Primary completion
—
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject FOLITIXORIN Small molecule — —
Subject fluorouracil Small molecule — —